Company / Total Assets
SUTRO BIOPHARMA, INC. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$173.8M
FY2025
5-year range
$173.8M / $470.7M
FY2021-FY2025
Trend
-55.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 8 years, ranging from $156M in FY2019 to $471M in FY2023.
Based on SEC 10-K filings.
$174M in FY2025 with a 5-year CAGR of -15.1%.
Declined from $471M to $174M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -24.7%
- 5-Year CAGR
- -15.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.1%, indicating a declining trend.
- In FY2025, total assets decreased 55.1% year-over-year.
- Peak total assets was recorded in FY2023.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $173.8M | -55.1% |
| FY2024 | $387.2M | -17.7% |
| FY2023 | $470.7M | +15.7% |
| FY2022 | $406.9M | +19.2% |
| FY2021 | $341.4M | -13.4% |
| FY2020 | $394.1M | +152.0% |
| FY2019 | $156.4M | -29.9% |
| FY2018 | $223.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026